Table 1. Clinicopathological features and NLR.
Characteristics | N (%), (n=128) | High NLR1 (n=70) | Low NLR1 (n=58) | P-value | High NLR2 (n=34) | Low NLR2 (n=94) | P-value |
---|---|---|---|---|---|---|---|
Gender | |||||||
Female | 30 (23.4) | 14 | 16 | 4 | 26 | ||
Male | 98 (76.6) | 56 | 42 | 30 | 68 | ||
Tumor location | |||||||
Left colon | 40 (31.2) | 18 | 22 | 8 | 32 | ||
Right colon | 28 (21.9) | 16 | 12 | 10 | 18 | ||
Rectum | 60 (46.9) | 36 | 24 | 16 | 44 | ||
Metastatic sites | |||||||
Lung metastatic | 26 (20.3) | 14 | 12 | 6 | 20 | ||
Liver metastatic | 48 (37.5) | 26 | 22 | 14 | 34 | ||
Lung and liver metastatic | 14 (10.9) | 6 | 8 | 2 | 12 | ||
Other | 40 (31.3) | 24 | 16 | 12 | 28 | ||
Number of metastatic sites | |||||||
0–2 | 88 (68.7) | 46 | 42 | 22 | 66 | ||
>2 | 40 (31.3) | 24 | 16 | 12 | 28 | ||
ORR | 40% | 68.90% | <0.001 | 23.50% | 63.80% | <0.001 |
NLR, neutrophil-to-lymphocyte ratio; ORR, objective response rate.